Related Experiment Video

Updated: Jul 17, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
09:44

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

Growth retardation in pediatric Crohn's disease: pathogenesis and interventions

Raanan Shamir1, Moshe Phillip, Arie Levine

  • 1Pediatric Gastroenterology Division of the Meyer Children's Hospital, Haifa.

Inflammatory Bowel Diseases
|January 31, 2007
PubMed

Insights

Growth retardation in Crohn's disease (CD) is a complex issue influenced by nutrition and inflammation. Understanding its mechanisms is key to improving growth in affected children and adolescents.

Area of Science:

  • Pediatric gastroenterology
  • Growth disorders
  • Inflammatory bowel disease

Background:

  • Growth retardation (GR) significantly impacts children and adolescents with Crohn's disease (CD).
  • GR can manifest before overt gastrointestinal symptoms in CD patients.
  • It is a multifactorial condition involving nutrition, inflammation, disease severity, and genetics.

Purpose of the Study:

  • To review current knowledge on the mechanisms of growth retardation in pediatric Crohn's disease.
  • To identify gaps in understanding the complex interactions contributing to GR.
  • To evaluate the efficacy of various treatment strategies for promoting growth in CD.

Main Methods:

  • Literature review of current evidence on growth retardation in Crohn's disease.
  • Analysis of the role of nutritional status, inflammation, and genetics.
  • Examination of the impact of inflammatory cytokines like TNF-alpha, IL-6, and IL-1 beta.
  • Assessment of treatment modalities for growth promotion.

Main Results:

  • Growth retardation in CD results from a complex interplay of factors.
  • Inflammatory cytokines (TNF-alpha, IL-6, IL-1 beta) play a crucial role.
  • Genetic factors contribute to growth hormone resistance.
  • Nutritional status and disease severity are significant determinants.

Conclusions:

  • GR in pediatric CD is a complex condition requiring a multifaceted approach.
  • Targeting inflammation and improving nutritional status are critical.
  • Further research is needed to optimize growth-promoting therapies in CD.

More Related Videos

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease05:08

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

Published on: March 1, 2022

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD: